ARTICLE | Company News
StemImmune, Accurexa deal
October 24, 2016 7:00 AM UTC
Accurexa and StemImmune partnered to develop stem cell-mediated immunotherapies to treat brain cancer. StemImmune referred inquiries to Accurexa, which declined to disclose financial terms....